Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD) Insider Trading
Directors, officers and holders of more than 10% of AARD report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 53 transactions on file: 13 with code P, 2 with code S and 35 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 7, 2026 | Zhang Zhongwei | Director | A Award | 127,061 | Not measured | Not measured |
| Sep 11, 2026 | Sun Nelson | See Remarks | S Sale | 62,000 | $5.18 | $321,179 |
| Sep 10, 2026 | Sun Nelson | See Remarks | S Sale | 14,754 | $5.00 | $73,779 |
| Aug 14, 2026 | Chi Jeffrey | Director | A Award | 44,964 | Not measured | Not measured |
| Aug 14, 2026 | Tong Victor Edward Jr | Director | A Award | 44,964 | Not measured | Not measured |
| Aug 14, 2026 | Baynes Roy D. | Director | A Award | 44,964 | Not measured | Not measured |
| Aug 14, 2026 | Graf Susan E | Director | A Award | 44,964 | Not measured | Not measured |
| Feb 9, 2026 | Lee Tien-Li | Chief Executive Officer | A Award | 203,851 | Not measured | Not measured |
| Feb 9, 2026 | Sun Nelson | See Remarks | A Award | 70,549 | Not measured | Not measured |
| Feb 9, 2026 | Jaiman Manasi | Chief Medical Officer | A Award | 70,549 | Not measured | Not measured |
| Dec 11, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 7,000 | $14.48 | $101,395 |
| Dec 11, 2025 | Sun Nelson | See Remarks | P Purchase | 3,000 | $14.40 | $43,200 |
| Oct 15, 2025 | Jones Bryan | Chief Operating Officer | M Exercise | 1,250 | Not measured | Not measured |
| Oct 15, 2025 | Jones Bryan | Chief Operating Officer | M Exercise | 1,250 | $4.24 | $5,300 |
| Oct 15, 2025 | Lee Tien-Li | Chief Executive Officer | M Exercise | 1,229 | Not measured | Not measured |
| Oct 15, 2025 | Lee Tien-Li | Chief Executive Officer | M Exercise | 1,229 | $4.24 | $5,211 |
| Sep 15, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 6,500 | $9.51 | $61,819 |
| Sep 15, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 3,500 | $9.94 | $34,805 |
| Sep 12, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 5,000 | $8.50 | $42,516 |
| Sep 11, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 6,000 | $7.82 | $46,926 |
| Sep 10, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 9,000 | $7.91 | $71,213 |
| Sep 9, 2025 | Sun Nelson | See Remarks | P Purchase | 6,000 | $8.07 | $48,440 |
| Aug 28, 2025 | Lee Tien-Li | Chief Executive Officer | M Exercise | 17,209 | $4.24 | $72,966 |
| Aug 28, 2025 | Lee Tien-Li | Chief Executive Officer | M Exercise | 17,209 | Not measured | Not measured |
| Jun 11, 2025 | Tong Victor Edward Jr | Director | A Award | 61,017 | Not measured | Not measured |
| Jun 11, 2025 | Lee Tien-Li | Chief Executive Officer | A Award | 549,534 | Not measured | Not measured |
| Jun 11, 2025 | Chi Jeffrey | Director | A Award | 61,017 | Not measured | Not measured |
| Jun 11, 2025 | Baynes Roy D. | Director | A Award | 30,508 | Not measured | Not measured |
| Jun 11, 2025 | Jaiman Manasi | Chief Medical Officer | A Award | 126,999 | Not measured | Not measured |
| Jun 11, 2025 | Jones Bryan | Chief Operating Officer | A Award | 122,033 | Not measured | Not measured |
| Jun 11, 2025 | Sun Nelson | See Remarks | A Award | 209,826 | Not measured | Not measured |
| Jun 11, 2025 | Graf Susan E | Director | A Award | 30,508 | Not measured | Not measured |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | P Purchase | 625,000 | $16.00 | $10,000,000 |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | C Conversion | 2,825,337 | Not measured | Not measured |
| Feb 14, 2025 | Chi Jeffrey | Director | C Conversion | 1,130,135 | Not measured | Not measured |
| Feb 14, 2025 | Cormorant Asset Management, LP | 10% Owner | C Conversion | 6,780,810 | Not measured | Not measured |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | P Purchase | 625,000 | $16.00 | $10,000,000 |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | C Conversion | 13,875,429 | Not measured | Not measured |
| Feb 14, 2025 | Vickers Venture Fund VI Pte Ltd | 10% Owner | C Conversion | 3,503,919 | Not measured | Not measured |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer | C Conversion | 350,002 | Not measured | Not measured |
| Feb 14, 2025 | Sun Nelson | See Remarks | C Conversion | 59,332 | Not measured | Not measured |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | C Conversion | 333,412 | Not measured | Not measured |
| Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | C Conversion | 2,333,887 | Not measured | Not measured |
| Feb 14, 2025 | Sun Nelson | See Remarks | P Purchase | 10,000 | $16.00 | $160,000 |
| Feb 14, 2025 | Sun Nelson | See Remarks | C Conversion | 7,001 | Not measured | Not measured |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer | P Purchase | 16,542 | $16.00 | $264,672 |
| Feb 14, 2025 | Cormorant Asset Management, LP | 10% Owner | P Purchase | 187,500 | $16.00 | $3,000,000 |
| Feb 14, 2025 | Cormorant Asset Management, LP | 10% Owner | C Conversion | 800,189 | Not measured | Not measured |
| Feb 14, 2025 | Chi Jeffrey | Director | C Conversion | 133,364 | Not measured | Not measured |
| Feb 14, 2025 | Lee Tien-Li | Chief Executive Officer | C Conversion | 41,303 | Not measured | Not measured |
The full Form 4 history is on the AARD company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.